Olanzapine plus modafinil + Olanzapine plus placebo
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Weight Gain
Conditions
Weight Gain
Trial Timeline
Jul 1, 2006 → Aug 1, 2007
NCT ID
NCT00636896About Olanzapine plus modafinil + Olanzapine plus placebo
Olanzapine plus modafinil + Olanzapine plus placebo is a pre-clinical stage product being developed by Eli Lilly for Weight Gain. The current trial status is completed. This product is registered under clinical trial identifier NCT00636896. Target conditions include Weight Gain.
What happened to similar drugs?
4 of 20 similar drugs in Weight Gain were approved
Approved (4) Terminated (1) Active (15)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00636896 | Pre-clinical | Completed |
Competing Products
20 competing products in Weight Gain